Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Dr. David Graham, a courageous FDA expert, blew the whistle and started a cascade of events that ultimately led to Merck & Co., Inc.'s withdrawal of its blockbuster drug Vioxx. Recently, he testified in Congress that Vioxx could be “the single greatest drug catastrophe of this country.” Various experts have postulated that Vioxx may be directly responsible for 20,000 to 160,000 heart attacks or strokes with perhaps as many as 40,000 deaths.
What happened? Should Merck be held responsible? This article, which is a condensation of a paper presented at a national Vioxx conference in November 2004, will present a very brief overview of the Vioxx controversy from a plaintiff's perspective. Portions in quotations are taken from the “Plaintiffs' Initial Statement/Position Paper,” prepared by the members of the PSC Executive Committee and filed in In Re: Vioxx Products Liability Litigation, MDL 1657, USDC ED, LA.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
A federal district court in Miami, FL, has ruled that former National Basketball Association star Shaquille O'Neal will have to face a lawsuit over his promotion of unregistered securities in the form of cryptocurrency tokens and that he was a "seller" of these unregistered securities.
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
Blockchain domain names offer decentralized alternatives to traditional DNS-based domain names, promising enhanced security, privacy and censorship resistance. However, these benefits come with significant challenges, particularly for brand owners seeking to protect their trademarks in these new digital spaces.
Mission Product Holdings, Inc. v. Tempnology, LLC The question is whether a debtor's rejection of its agreement granting a license "terminates rights of the licensee that would survive the licensor's breach under applicable nonbankruptcy law."